MediaNewsPublicationsVideosAwareness CampaignsNewsPrintTweet03/02/2021The Josep Carreras Leukaemia Research Institute, new Member Institution at the International Cancer Proteogenome Consortium of the National Cancer Institute.More03/01/2021New additions to the Josep Carreras Leukemia Research InstituteMore02/19/2021Adding genomics criteria to the classification of Myelodysplastic Syndromes improves its prognosisMore02/11/2021Researchers from Josep Carreras Institute participate in the program 100tífiques aimed at fostering science careers among school girlsMore02/11/2021An international team measures the importance of the genetic background in cancer immunotherapyMore02/05/2021Anna Bigas, new Deputy Director of Preclinical Research at the Josep Carreras Leukemia Research InstituteMore02/05/2021Anna Bigas, new Deputy Director of Preclinical Research at the Josep Carreras Leukemia Research InstituteMore01/18/2021New epigenetic targets identified for the potential treatment of multiple myelomaMore12/31/2020Discovered the explanation of the patients with “lazarus-like” cancerMore12/29/2020New advances in acute lymphoblastic leukaemia in adultsMoreFirstPrevious12345678910NextLastWebpage updated 10/16/2019 13:23:15
03/02/2021The Josep Carreras Leukaemia Research Institute, new Member Institution at the International Cancer Proteogenome Consortium of the National Cancer Institute.More
02/19/2021Adding genomics criteria to the classification of Myelodysplastic Syndromes improves its prognosisMore
02/11/2021Researchers from Josep Carreras Institute participate in the program 100tífiques aimed at fostering science careers among school girlsMore
02/11/2021An international team measures the importance of the genetic background in cancer immunotherapyMore
02/05/2021Anna Bigas, new Deputy Director of Preclinical Research at the Josep Carreras Leukemia Research InstituteMore
02/05/2021Anna Bigas, new Deputy Director of Preclinical Research at the Josep Carreras Leukemia Research InstituteMore
José Carreras Leukaemia Foundation